Guardant Health (GH) PT Lowered to $80 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $176.88 +2.10%
Rating Summary:
30 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 17
Rating Summary:
30 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 17
Join SI Premium – FREE
Goldman Sachs analyst Matthew Sykes lowered the price target on Guardant Health (NASDAQ: GH) to $80.00 (from $90.00) while maintaining a Buy rating.
You May Also Be Interested In
- Guardant Health (GH) PT Raised to $210 at BTIG, remains Top Pick
- Zymeworks (ZYME) PT Raised to $35 at Truist Securities
- Innio NV (INIO) PT Lowered to $35 at BNP Paribas Exane
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
